Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABIOMED INCNASD · Entity 121309 | Director | August 10, 2022 | August 12, 2022 |
| Orchestra BioMed Holdings, Inc.OBIO · Entity 434 | Director | June 20, 2024 | June 21, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABIOMED INC
Report date August 10, 2022 · Filed August 12, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 par valueSEC Table I · non-derivative | Direct | 15,203 |
Ending reported balance
After 2022-08-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-08-10 · Grant · Acquired 681 · Balance 15,516 F1: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) the first anniversary of the date of grant; and (b) the date of the Corporation's 2023 Annual Meeting; that such awards shall be subject to a -Restricted Stock Unit Award Agreement in accordance with the Second Amended & Restated 2015 Omnibus Incentive Plan. Row 2 · 2022-08-11 · Tax withholding · Disposed 313 · Balance 15,203 F2: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) the first anniversary of the date of grant; and (b) the date of the Corporation's 2023 Annual Meeting; that such awards shall be subject to a -Restricted Stock Unit Award Agreement in accordance with the Second Amended & Restated 2015 Omnibus Incentive Plan.
F2: Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
Orchestra BioMed Holdings, Inc.
Report date June 20, 2024 · Filed June 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per share ("Common Stock")SEC Table I · non-derivative | Direct | 7,544 |
Reported balance
After 2024-06-20 transaction · row 1
1 source rowRow 1 · 2024-06-20 · Grant · Acquired 5,376 · Balance 7,544 F1: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 20, 2025. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.44 · Expires 2034-06-20 | Direct | 17,068 |
Reported balance
After 2024-06-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-06-20 · Grant · Acquired 17,068 · Balance 17,068 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 20, 2025.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SIGA TECHNOLOGIES INC
Report date June 15, 2021 · Filed June 17, 2021
Section 16 reporting ended · disclosed 2021-06-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.0001 per shareSEC Table I · non-derivative | Direct | 1,068,593 |
Reported balance
After 2021-06-15 transaction · row 1
1 source rowRow 1 · 2021-06-15 · Exercise / conversion · Acquired 15,000 · Balance 1,068,593 F1: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-06-15 · Exercise / conversion · Disposed 15,000 · Balance 0 F1: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis. F2: The RSUs were granted on June 16, 2020, and fully vested on the date of, and immediately prior to, the Company's 2021 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.
F2: The RSUs were granted on June 16, 2020, and fully vested on the date of, and immediately prior to, the Company's 2021 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2017 Filed Aug 11, 2017 16:10 UTC | ABIOMED INC ABMD · Entity 121309 | GrantCommon Stock, $.01 par value | 1,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011394 · edgar.xml · nonDerivative · entry 1 ROSE ERIC A MD · CIK 0001139301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,542 F2 · kind: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the later of: (a) August 9, 2018; or (b) the date of the Issuer's next annual meeting of stockholders. F2 · shares: Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the later of: (a) August 9, 2018; or (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:19 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | Exercise / conversionRestricted Stock Units · Derivative | 66,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-000873 · form4.xml · derivative · entry 3 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.0001 per share · 66,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents vesting and conversion of certain RSUs granted on January 3, 2014. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. F2 · derivative.exercise_date: Represents vesting and conversion of certain RSUs granted on January 3, 2014. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. F2 · derivative.expiration_date: Represents vesting and conversion of certain RSUs granted on January 3, 2014. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:19 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | Tax withholdingCommon Stock, par value $.0001 per share | 29,502 | $2.93 | $86,440.86 |
DisclosureSEC source: 0001140361-17-000873 · form4.xml · nonDerivative · entry 2 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,928 F1 · shares: SIGA Technologies, Inc. (the "Issuer") has certain tax withholding obligations associated with the vesting of restricted stock units ("RSUs") and the consequent issuance of Common Stock of the Issuer. This Form 4 reports the surrender to the Issuer by the Reporting Person of 29,502 shares of Common Stock -- granted in the form of RSUs on January 3, 2014 -- in order to satisfy those withholding tax obligations. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 01:19 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | Exercise / conversionCommon Stock, par value $.0001 per share | 66,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-000873 · form4.xml · nonDerivative · entry 1 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 22:33 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | Exercise / conversionRestricted Stock Units · Derivative | 66,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-089411 · form4.xml · derivative · entry 5 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,667 Underlying: Common Stock, par value $.0001 per share · 66,668 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents vesting and conversion of certain RSUs granted on January 3, 2014. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. F3 · derivative.exercise_date: Represents vesting and conversion of certain RSUs granted on January 3, 2014. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. F3 · derivative.expiration_date: Represents vesting and conversion of certain RSUs granted on January 3, 2014. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 22:33 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | Exercise / conversionRestricted Stock Units · Derivative | 66,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-089411 · form4.xml · derivative · entry 4 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.0001 per share · 66,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents vesting and conversion of certain RSUs granted on January 3, 2013. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. F2 · derivative.exercise_date: Represents vesting and conversion of certain RSUs granted on January 3, 2013. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. F2 · derivative.expiration_date: Represents vesting and conversion of certain RSUs granted on January 3, 2013. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 22:33 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | Tax withholdingCommon Stock, par value $.0001 per share | 68,469 | $3.13 | $214,307.97 |
DisclosureSEC source: 0001140361-16-089411 · form4.xml · nonDerivative · entry 3 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 647,763 F1 · shares: SIGA Technologies, Inc. (the "Issuer") has certain tax withholding obligations associated with the vesting of restricted stock units ("RSUs") and the consequent issuance of Common Stock of the Issuer. This Form 4 reports the surrender to the Issuer by the Reporting Person of 68,469 shares of Common Stock -- granted in the form of RSUs on January 3, 2013 and January 3, 2014 -- in order to satisfy those withholding tax obligations. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 22:33 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | Exercise / conversionCommon Stock, par value $.0001 per share | 66,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-089411 · form4.xml · nonDerivative · entry 2 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 22:33 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | Exercise / conversionCommon Stock, par value $.0001 per share | 66,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-089411 · form4.xml · nonDerivative · entry 1 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:11 UTC | ABIOMED INC ABMD · Entity 121309 | Exercise / conversionStock option (right to buy) · Derivative | 8,000 | $0.00 Strike: $12.69 | $0.00 |
DisclosureSEC source: 0001179110-16-032321 · edgar.xml · derivative · entry 4 ROSE ERIC A MD · CIK 0001139301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2017-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Grant to report person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan. F3 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F3 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:11 UTC | ABIOMED INC ABMD · Entity 121309 | SaleCommon Stock, $.01 par value | 4,559 | $111.16 | $506,797.13 |
DisclosureSEC source: 0001179110-16-032321 · edgar.xml · nonDerivative · entry 3 ROSE ERIC A MD · CIK 0001139301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,259 F3 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F3 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F5 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $111.0400 and $111.3250. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:11 UTC | ABIOMED INC ABMD · Entity 121309 | SaleCommon Stock, $.01 par value | 3,441 | $110.34 | $379,670.65 |
DisclosureSEC source: 0001179110-16-032321 · edgar.xml · nonDerivative · entry 2 ROSE ERIC A MD · CIK 0001139301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,818 F3 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F3 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F4 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $110.0100 and $110.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 16:11 UTC | ABIOMED INC ABMD · Entity 121309 | Exercise / conversionCommon Stock, $.01 par value | 8,000 | $12.69 | $101,520.00 |
DisclosureSEC source: 0001179110-16-032321 · edgar.xml · nonDerivative · entry 1 ROSE ERIC A MD · CIK 0001139301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Sale of common stock pursuant to reporting owner's 10b5-1 plan. F3 · shares: Sale of common stock pursuant to reporting owner's 10b5-1 plan. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 21:08 UTC | SIGA TECHNOLOGIES INC SIGA · Entity 6205 | GrantRestricted Stock Units · Derivative | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-087776 · form4.xml · derivative · entry 1 ROSE ERIC A MD · CIK 0001139301 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock, par value $.0001 per share · 300,000 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted to the reporting person pursuant to the reporting person's amended and restated employment agreement as Executive Chairman of the Company and in accordance with the terms of the Company's 2010 Stock Incentive Plan. Each RSU converts into one share of Common Stock of the Issuer on a one for one basis. F2 · derivative.exercise_date: The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant. F2 · derivative.expiration_date: The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.